Asthma Clinical Trials in Phoenix

Showing 301-320 of 348 trials

Sofia RSV FIA Field Study

NCT01734668

The objective of this study is to demonstrate the clinical performance of the Sofia RSV FIA with specimens from symptomatic pediatric subjects who are less than nineteen (19) years of age.

Respiratory Syncytial Virus

Quidel Corporation2,468 participantsStarted Mar 2012

Phoenix, Arizona, United States • Panorama City, California, United States • Boynton Beach, Florida, United States +14 more locations

COMPLETEDPhase 211 miles

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

NCT01545440

This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will assess the efficacy and safety of lebrikizumab in patients with asthma whose disease remains uncontrolled despite daily therapy with an inhaled corticosteroid and a second controller medication. Patients will be randomized in a 1:1:1:1 ratio to receive double-blind treatment with subcutaneous lebrikizumab ("highest", "middle", "lowest" dose) or placebo every 4 weeks for 52 weeks, in addition to their standard-of-care therapy. This will be followed by a 52-week double-blind active treatment extension. The anticipated time on study treatment is up to 104 weeks. There will be a safety follow-up of 24 weeks after the last dose of study drug for all patients.

Asthma

Genentech, Inc.258 participantsStarted Mar 2012

Pell City, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +68 more locations

Sofia RSV FIA Field Study

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Asthma Trials in Other Cities

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma

Study of Acid Reflux in Asthma

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)

Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

Other Conditions in Phoenix